Selected SummaryInfluence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease (Gastroenterology 2009;137:1628-1640)
Geom Seog Seo
Intestinal Research 2009;7(2):135-136. Published online: December 30, 2009